ADAMTS13 and von Willebrand factor are useful biomarkers for sorafenib treatment efficiency in patients with hepatocellular carcinoma

doi:10.4251/wjgo.v11.i5.424

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6003)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

380

WORD

284

HTML

3012

Figures (1-5)

134

Tables (1-3)

135

Sum=3945

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

823

Download

1235

Sum=2058

May 15, 2019 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastrointest Oncol. May 15, 2019; 11(5): 424-435
Published online May 15, 2019. doi: 10.4251/wjgo.v11.i5.424

Full Size Figure Download Figure

Figure 2 The relationship between the VWF:Ag/ADAMTS13:AC ratio and tumor-node-metastasis stage. The VWF:Ag/ADAMTS13:AC ratio level was significantly higher in patients with tumor-node-metastasis stage 4 hepatocellular carcinoma (HCC) than those with stage 2 and 3 HCC. ADAMTS13: A disintegrin-like and metalloproteinase with thrombospondin type 1 motifs 13; ADAMTS13:AC: ADAMTS13 activity; VWF: Von Willebrand factor; VWF:Ag: VWF antigen; VWF:Ag/ADAMTS13:AC ratio: The ratio of VWF:Ag to ADAMTS13:AC; TNM stage: Tumor-node-metastasis stage.

Citation: Takaya H, Namisaki T, Shimozato N, Kaji K, Kitade M, Moriya K, Sato S, Kawaratani H, Akahane T, Matsumoto M, Yoshiji H. ADAMTS13 and von Willebrand factor are useful biomarkers for sorafenib treatment efficiency in patients with hepatocellular carcinoma. World J Gastrointest Oncol 2019; 11(5): 424-435
URL: https://www.wjgnet.com/1948-5204/full/v11/i5/424.htm
DOI: https://dx.doi.org/10.4251/wjgo.v11.i5.424